CMCSA has now absorbed another target reduction this morning. Barclays cut to $24 from $26 — the sixth analyst reduction since mid-September. The stock closed at $21.79, already below most of the Street's revised targets.
Barclays' Kannan Venkateshwar maintained Equal-Weight but trimmed for the second time since July. The mean consensus target is now $28.97. That still implies 33% upside — but it has been shrinking with every cut, not expanding.
The full recent scorecard: Morgan Stanley cut to $27 on September 28. Citigroup cut to $27.50 on September 24. UBS cut to $27 on September 15. BofA cut to $35 on September 16. KeyBanc went furthest — Underweight, $18 target, still the Street's lowest.
Not one firm has raised its target in two months.
The stock is down 19.5% over the past month. The PE sits at 6.2x. Price-to-book is 0.77. These are distressed-value multiples for a large-cap media and broadband company. Earnings are October 22 — that is the next hard data point.
The put-call ratio sits at 0.44 today. The 20-day mean is 0.37. The z-score is 1.65 — elevated, but not at a signal threshold. Options markets remain skewed toward protection. They are not panicking.
The PCR peaked at 0.46 earlier this week before pulling back slightly. That move coincided with the KeyBanc downgrade. The positioning is consistent across both sessions — cautious, hedged, watching October 22.
SI is 2.0% of free float — low by any measure. It has fallen roughly 5.2% over the past week and is effectively flat over 30 days. Short sellers are not piling in despite the analyst pressure.
Borrow availability sits at 9,101% — meaning there are roughly 91 shares available to borrow for every one already borrowed. The lending market is as loose as it has been in over a year. There is no squeeze risk. There is no borrow constraint. Short sellers can enter or exit freely, and they are choosing to exit.
This is the same divergence flagged in the previous two reports: the narrative is bearish, the positioning is not.
October 22 is the line in the sand. Between now and then, any further analyst cuts will narrow the consensus target further — at $21.79, two or three more reductions could push the stock above the mean target from below. The Barclays move today is a reminder that the reset is still in progress.
See the live data behind this article on ORTEX.
Open CMCSA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
